P3.02b-087 Dose Escalation Study of CDDP plus PEM with Erlotinib and Bev Followed by PEM with Erlotinib and Bev for Non-SQ NSCLC Harboring EGFR Mutations: Topic: EGFR Clinical
Journal of Thoracic Oncology(2017)
关键词
EGFR,non-small cell lung cancer,maintenance therapy,combination chemotherapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要